Skip to content
Biopharma EHS Podcast Episode No. 17 episode artwork

Dec 23, 2011 30 min

Biopharma EHS Podcast Episode No. 17

from Biopharma EHS

Containment Validation and Surrogate Monitoring In this episode of the Biopharma EHS podcast, Dean M. Calhoun, CIH, President and CEO of Affygility Solutions discusses the following topics: A review of Episode no. 16 of the Biopharma EHS podcast. In that episode, Dean M. Calhoun, President and CEO of Affygility Solutions, and Dr. Joe Nieusma, Sr. Occupational Toxicologist with Affygility Solutions discuss Category 4 and 5 potent compounds. Our discussions include what factors determine a Category 4 or 5 potent compound, why the occupational exposure limit (OEL) alone is not enough to determine if a specific compound falls into a category 4 or 5 control band, and specific examples of potent compounds that are classified into these control bands. An interview with Matt Meiners, Division Manager, Laboratory Services for the Bureau Veritas, Lake Zurich, Industrial Hygiene Laboratory. In this interview, Dean and Matt discuss containment validation and surrogate monitoring. Often call SMEPAC testing. Matt provides insight into why containment validation is necessary, the advantages and disadvantages of different surrogate compounds, the sensitivity of their industrial hygiene laboratory methods for surrogate compounds, the advantages and disadvantages of the total dust versus the Institute of Occupational Medicine (IOM) method of sampling. Upcoming events and happenings of interest to environmental, health and safety professionals in the biotechnology, pharmaceutical, and medical device industries. These events include: Affygility Solutions' webinars. These webinars include: Advance Topics in Potent Compound Safety Dermal Exposure and Absorption of Active Pharmaceutical Ingredients Isoflurane Safety Society of Toxicology Annual Meeting in San Francisco, CA Society of Chemical Hazard Communication Spring Meeting in Nashville, TN The above webinars are a great way for environmental, health and safety professionals to obtain certification maintenance points. If you have questions regarding this podcast, please email podcast @ affygility.com

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Biopharma EHS Podcast Episode No. 17

0:00 30:06

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

BioCentury This Week BioCentury BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem. Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Jesús E. Moreno Hosted by Jesús E. Moreno (Business Development Director, bioaccess®), Global Trial Accelerators™ is a clinical trials podcast for life-sciences founders and innovators in MedTech, Biotech/Biopharma, and Radiopharma, focused on first-in-human (FIH) and early feasibility studies. The show is produced by bioaccess® and was founded by Co-Founder & CEO Julio G. Martinez-Clark. bioaccess® is a CRO purpose-built for first-in-human (FIH) trials, serving MedTech, Biopharma, and Radiopharma startups. This podcast delivers strategies, regulatory insights, and founder stories to get your technology into humans faster and affordably, with data designed to support FDA and EMA submissions. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and founders who have compressed timelines, reduced costs, and generated the clinical evidence investors demand by drawing on on-demand clinical research capability across the Americas. What You Business Of Biotech Ben Comer The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Life Science Connect. BioBoss John Simboli BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

Frequently asked questions

How long is this episode of Biopharma EHS?

This episode is 30 minutes long.

When was this Biopharma EHS episode published?

This episode was published on December 23, 2011.

Can I download this Biopharma EHS episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.